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Abstract
The influence of diabetes on the response of isolated rabbit renal arteries to 5-hydroxytryptamine (5-HT) was examined. 5-HT induced a
concentration-related contraction that was higher in arteries from diabetic rabbits than in arteries from control rabbits. Endothelium removal
did not significantly modify 5-HT contractions in arteries from control rabbits but enhanced the response to 5-HT in arteries from diabetic
rabbits. Incubation with NG-nitro-L-arginine (L-NA) enhanced contractions to 5-HT in arteries from control and diabetic rabbits. In arteries
with endothelium, this L-NA enhancement was lower in diabetic rabbits than in control rabbits. In arteries without endothelium, incubation
with L-NA enhanced the maximal contractions to 5-HT in control rabbits but did not in diabetic rabbits. Indomethacin inhibited 5-HT-induced
contraction of arteries from control rabbits and enhanced the maximal contraction to 5-HT of arteries from diabetic rabbits. In summary,
diabetes enhances contractile response of rabbit renal artery to 5-HT. In control animals, this response is regulated by both endothelial and
non-endothelial (neuronal) nitric oxide (NO) and by a vasoconstrictor prostanoid. Diabetes impairs the release of non-endothelial NO and the
vasoconstrictor prostanoid. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Diabetic nephropathy is a leading cause of end-stage
renal disease in the Western world, and its prevalence and
incidence vary greatly from country to country, being high-
est in the United States and Japan. In the United States,
diabetes is the underlying cause of about 40% of all kidney
failure (Akmal, 2001). In Spain, diabetic nephropathy
accounts for 30% of patients with renal failure (Caravaca
et al., 2001). Diabetes is an independent risk factor for
mortality in patients receiving peritoneal dialysis (Sancho et
al., 2001) and increases the economic costs in dialysis with
respect to the nondiabetic patients (Yang et al., 2001).
The endothelium contributes to the regulation of vascular
reactivity through the release of different constrictor (angio-
tensin II, endothelin-1, thromboxane A2, prostaglandin H2)
or relaxant [nitric oxide (NO), prostacyclin, endothelium-
derived hyperpolarizing factor] substances, the equilibrium
of which results in vascular tone. Changes in the regulatory
activity of endothelium have been implicated in the patho-
genesis of diabetic nephropathy (Rabelink and Bakris,
1998). Immunohistochemical techniques show a reduced
expression of NO synthase (NOS) in macula densa cells of
diabetic kidneys (Yagihashi et al., 1996). In contrast, other
studies suggest that excessive production of NO may con-
tribute to renal hyperfiltration and hyperperfusion of dia-
betic nephropathy (Sugimoto et al., 1998; Choi et al., 1999).
In addition, the observed increased renal production of
thromboxane A2 and prostacyclin has claimed to be
involved in the pathogenesis of renal diabetic damage
(Okumura et al., 2000).
On the other hand, several reports suggest a possible role
for 5-hydroxytryptamine (5-HT) in the pathophysiology of
the renal diabetic complications. The reactivity of the renal
vasculature towards 5-HT is changed in diabetic spontane-
ously hypertensive rats (Boston and Hodgson, 1997). More-
over, the fact that diabetes enhances plasma concentration of
5-HT and that 5-HT enhances the production of type IV
collagen by human mesangial cells leads to suggest the
involvement of 5-HT in the development of renal diabetic
changes (Kasho et al., 1998). Finally, a clinical study
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achieved in non-insulin-dependent diabetes mellitus patients
suggests the potential benefits of the use of the 5-HT2
receptor antagonist sarpogrelate in the treatment of diabetic
nephropathy (Ogawa et al., 1999).
We have recently described that experimental diabetes
induces changes in endothelial-mediated relaxant responses
of rabbit renal (Alabadı´ et al., 2001) and carotid (Miranda et
al., 2000a) arteries. In addition, we have also reported that
diabetes enhances the sensitivity of the rabbit carotid artery
to 5-HT (Miranda et al., 2000b). The aim of the present
study was to analyse diabetes-induced changes in the
reactivity of the renal artery to 5-HT, including the study
of the mechanisms that regulate this response. To do this, we
studied the influence of alloxan-induced diabetes on mod-
ulatory mechanisms of the constrictor response of rabbit
renal artery to 5-HT.
2. Methods
Thirty-eight male New Zealand white rabbits were used
in the present study. Animals were randomly divided into
two experimental groups: 20 in the control group and 18
destined for induction of experimental diabetes. Housing
conditions and experimental procedures were in accordance
with the European Union regulations on the use of animal
for scientific purposes (86/609/EEC, Article 5, Appendix II)
and promulgated by Spanish legislation on March 14, 1988
(R.D. 223/1988).
2.1. Induction of diabetes and control animals
For induction of experimental diabetes, rabbits weighing
2.0–3.2 kg were sedated with intramuscular 40 mg of
ketamine (KetolarR). Diabetes was induced by injecting
alloxan (100 mgkg 1) into the lateral ear vein. To prevent
hypoglycaemia, 10 ml of glucose 5% was injected (i.v.) after
the alloxan and drinking water was supplemented with 10%
glucose for the first 24 h after the alloxan injection. There-
after, the animals were maintained on tap water and regular
food ad libitum for 6 weeks. A second group of rabbits (2.1–
3.0 kg) was maintained under the same conditions for the
same time period to serve as age-matched controls (hence-
forth ‘‘control rabbits’’). Diabetic rabbits showed a marked
increase in serum glucose and a failure to increase their body
weight when compared with control rabbits. Table 1 shows
the mean values of body weight and glycaemia before and 6
weeks after diabetes induction for the rabbits in the diabetic
group and for the rabbits in the control group.
2.2. Isometric tension recording
Six weeks after diabetes induction, the diabetic and the
age-matched control rabbits were anaesthetised with sodium
thiopental (sodium pentothal, 2% i.v.) and killed by injection
of potassium chloride (10 mEq, 0.5 mlkg 1, i.v.). The renal
arteries were dissected free and cut into cylindrical segments
measuring 3–4 mm in length. Each segment was prepared
for isometric tension recording in an organ bath. Two
stainless steel L-shaped pins (diameter, 125 Am) were
introduced through the arterial lumen. One pin was fixed
to the organ bath wall and the other pin was connected to a
strain gauge for isometric tension recording. The organ bath
contained 5 ml of Ringer–Locke solution that was bubbled
continuously with 95% O2 and 5% CO2 to provide a pH of
7.3–7.4. Temperature was kept at 37 jC. A resting tension of
2 g was applied to the arterial segments, and they were
allowed to equilibrate for a period of 60–90 min before the
experiments were started. Tension was readjusted when
necessary and the bath fluid was changed every 15 min.
After this period of equilibration, the reactivity of the arterial
segments was checked by depolarisation with 50 mM KCl.
2.3. Concentration–response curves of 5-HT
The experiments were carried out with renal arteries from
both control and diabetic rabbits. Concentration–response
curves for 5-HT (10  8–3 10 6 M) were obtained by its
cumulative addition to the organ bath. To assess the influ-
ence of the endothelium on the effect of 5-HT, concentra-
tion–response curves were obtained with arteries from
which the endothelium had been removed by rubbing the
intimal surface with a scored stainless steel rod (rubbed
arteries). The absence of endothelium was examined by
silver staining (Caplan and Schwartz, 1973). To assess the
participation of NO in the response of renal arteries to 5-HT,
the concentration–response curves for this amine were
obtained after the incubation (20 min) of the unrubbed
arteries with the inhibitor of NOS NG-nitro-L-arginine (L-
NA, 10 4 M). Moreover, concentration–response curves
for 5-HT were obtained in rubbed arteries preincubated (20
min) with 10 4 M L-NA. The possibility that some arach-
idonic acid derivative could modulate the arterial response
to 5-HTwas examined by obtaining concentration–response
curves for 5-HT after incubation (20 min) of the unrubbed
arteries with indomethacin (10  5 M), an inhibitor of cyclo-
oxygenase. Finally, we also obtained concentration–
response curves for 5-HT in the presence of both L-NA
(10  4 M) and indomethacin (10  5 M).
Table 1
Values of body weight and glycaemia in control and diabetic rabbits
Body weight (kg) Glycaemia (mM) n
Control rabbits
Initial time 2.56F 0.09 5.9F 0.2 20
6 weeks after 3.58F 0.07 6.0F 0.2 20
Diabetic rabbits
Initial time 2.60F 0.09 6.0F 0.2 18
6 weeks after 3.01F 0.07a 20.7F 1.3a 18
Results are meansF S.E.M.
a Significantly different from corresponding value in control rabbits,
p< 0.05.
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2.4. Drugs and solutions
Alloxan, 5-HT and indomethacin were obtained from
Sigma and L-NA from Peptide Institute. Alloxan was dis-
solved in saline solution. 5-HT and L-NA were dissolved in
twice-distilled water and diluted in saline solution; the L-NA
solution required sonication to dissolve completely. Indo-
methacin was dissolved in ethanol and diluted in saline
solution. The composition of the Ringer–Locke solution
was (mM): NaCl, 120; KCl, 5.4; CaCl2, 2.2; MgCl2, 1.0;
NaHCO3, 25; and glucose, 5.6. To prepare the KCl-depo-
larising solution, NaCl was replaced by an equimolar
amount of KCl in the normal Ringer–Locke solution.
2.5. Statistical analysis
Comparisons of body weight and glycaemia between
control and diabetic rabbits were made by using unpaired
Student’s t-test. 5-HT-induced contractions are expressed as
a percentage of the previous depolarisation induced by 50
mM KCl. For each concentration– response curve, the
maximum effect (Emax) and the concentration of 5-HT that
produced half of Emax (EC50) were calculated. Maximum
effects are expressed as meansF standard error of the mean
(S.E.M.) and EC50 as the geometric mean with its con-
fidence limits (95%) for repeated experiments. Statistical
comparisons of Emax and  log EC50 (pD2) values between
arteries from control and diabetic rabbits receiving the same
experimental treatment were achieved by using unpaired
Student’s t-test. Comparisons between the values of Emax
and pD2 of the concentration–response curves for 5-HT
obtained with the different treatments in the arteries from the
control rabbits were made using analysis of variance
(ANOVA) followed by the Newman–Keuls test. The same
tests were used to compare Emax and pD2 values of the
curves obtained with the different treatments in the arteries
from diabetic rabbits. A probability value of less than 5%
was considered significant.
3. Results
Exposure of arterial segments from control rabbits to 50
mM KCl induced a contractile response (8187F 1057 mg)
that was not significantly different from that obtained in renal
arterial segments from diabetic rabbits (8092F 1133 mg).
5-HT (10  8 –3 10  6 M) induced concentration-
related contractions of the renal artery from either control or
diabetic rabbits (Fig. 1). The maximal contraction obtained
was significantly higher in arteries from diabetic rabbits with
respect to that obtained in arteries from control rabbits, with-
out significant differences between EC50 values (Table 2).
In arteries from control rabbits, mechanical removal of the
endothelium did not significantly modify the Emax nor EC50
values of the concentration–response curve to 5-HT (Fig. 1;
Table 2). In arteries from diabetic rabbits, mechanical
removal of the endothelium displaced to the left and strongly
enhanced the Emax value of the concentration–response
curve for 5-HT (Fig. 1; Table 2), being the maximal contrac-
tion significantly higher with respect to that obtained in
rubbed arteries from control rabbits (Table 2).
In arteries with endothelium, incubation with L-NA
(10  4 M) enhanced the contractions induced by 5-HT in
arterial segments from either control or diabetic rabbits,
without significant differences between EC50 values (Fig. 2;
Table 2). The maximal contraction to 5-HT in L-NA-treated
arteries from diabetic animals was significantly lower than
that obtained in arterial segments from control rabbits (Fig.
2; Table 2).
In arteries from control animals, the Emax value to 5-HTof
L-NA-treated arterial segments was also significantly higher
with respect to that obtained in rubbed arteries (Table 2). In
arteries from diabetic rabbits, the contractile response
induced by 5-HT in the presence of L-NA was not signifi-
cantly different with respect to that obtained in rubbed
arteries (Table 2).
In L-NA- (10  4 M) pretreated rubbed renal arteries
isolated from control rabbits, 5-HT induced a concentra-
tion-dependent contraction with an EC50 significantly lower
than that obtained in control arteries, and a maximal con-
traction significantly higher with respect to both control and
rubbed arteries but significantly lower with respect to L-NA
unrubbed arteries (Fig. 2; Table 2).
In arteries from diabetic rabbits, incubation of rubbed
segments with L-NA (10  4 M) induced a significant
enhancement of the contractile response to 5-HTwith respect
to their corresponding control, without significant differences
with respect to either rubbed or L-NA-treated arterial seg-
ments (Fig. 2; Table 2). The contractile response induced by
Fig. 1. Concentration– response contractile curves for 5-HT in renal arteries
isolated from control (open symbols) and diabetic (solid symbols) rabbits in
arteries with (circles) and without (squares) endothelium. Values represent
meansF S.E.M.
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5-HT in rubbed arteries preincubated with L-NA from dia-
betic animals was not significantly different with respect to
the contraction obtained in arteries with the same experimen-
tal treatment from control rabbits (Table 2).
In arteries from control rabbits, pretreatment of arterial
segments with indomethacin (10  5 M) significantly inhi-
bited the Emax of the concentration–response contractile
curve for 5-HT, without affecting the EC50 value (Fig. 3;
Table 2). In the presence of both L-NA (10  4 M) and
indomethacin (10  5 M), the concentration–response curve
for 5-HT exhibited an Emax significantly higher than that
obtained both in control and indomethacin-treated arteries
and significantly lower than that obtained in L-NA-treated
arteries, without significant differences between EC50 values
(Fig. 3; Table 2).
In arteries from diabetic rabbits, incubation with indo-
methacin (10  5 M) significantly enhanced the maximal
contraction to 5-HT (Fig. 3; Table 2). The Emax and EC50
values of the concentration–response curve for 5-HT ob-
tained in the presence of both L-NA (10 4 M) and indo-
methacin (10  5 M) were not significantly different with
respect to the other experimental situations in diabetic
rabbits (Fig. 3; Table 2).
4. Discussion
In this work, we have studied the influence of alloxan-
induced diabetes on the modulatory mechanisms of rabbit
renal arterial constrictor response to 5-HT. To do this, we
have used an experimental model of chemical diabetes in
the rabbit. The diabetogenic agent used was alloxan. This
drug induces in the animal a syndrome resembling type-I
diabetes mellitus, characterised by hyperglycaemia, hyper-
cholesterolemia, glycosuria and raised levels of glycosylated
hemoglobin in erythrocytes (Agrawal et al., 1987), and it is
Fig. 2. Concentration– response contractile curves for 5-HT in renal arteries
isolated from control (open symbols) and diabetic (solid symbols) rabbits in
different experimental conditions: control (circles), incubated with L-NA
10 4 M (triangles), and both rubbed and incubated with L-NA 10 4 M
(diamonds). Values represent meansF S.E.M.
Fig. 3. Concentration–response contractile curves for 5-HT in renal arteries
isolated from control (open symbols) and diabetic (solid symbols) rabbits in
different experimental conditions: control (circles), incubated with
indomethacin 10 5 M (squares), and incubated with both L-NA 10 4 M
and indomethacin 10 5 M (triangles). Values represent meansF S.E.M.
Table 2
EC50 and maximum effect (Emax) values for concentration– response curves
to 5-hydroxytryptamine in rabbit renal artery
Control rabbits EC50 ( 10 7 M) Emax (%) n
Control 3.4 (3.1–3.7) 22F 3 23
Rubbed 2.7 (2.3–3.1) 22F 4 21
L-NA 10 4 M 2.6 (2.2–2.9) 69F 7a,b 12
Rubbed + L-NA 10 4 M 1.7 (1.4–2.2)a 39F 11a,b,c 6
Indomethacin 10 5 M 4.1 (3.6–4.6) 9F 2a,b,c 15
L-NA 10 4 M+
indomethacin 10 5 M
2.6 (2.2–2.9) 50F 5a,b,c,d 10
Diabetic rabbits EC50 ( 10 7 M) Emax (%) n
Control 3.2 (2.9–3.5) 34F 4e 20
Rubbed 1.9 (1.7–2.2)a 56F 6a,e 19
L-NA 10 4 M 2.8 (2.5–3.1) 48F 4a,e 15
Rubbed + L-NA 10 4 M 2.7 (2.5–2.9) 52F 9a 12
Indomethacin 10 5 M 2.6 (2.1–3.2)e 52F 4a,e 7
L-NA 10 4 M+
indomethacin 10 5 M
1.9 (1.5–2.6) 50F 7 9
Emax values are expressed as a percentage of a previous depolarisation with
KCl 50 mM. EC50 values are means and confidence limits; Emax values are
means F S.E.M.; n: number of arterial segments.
a Significantly different from corresponding control value, p< 0.05.
b Significantly different from corresponding rubbed value, p< 0.05.
c Significantly different from corresponding L-NA 10 4 M value,
p< 0.05.
d Significantly different from corresponding indomethacin 10  5 M
value, p< 0.05.
e Significantly different from corresponding value in control rabbits,
p< 0.05.
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accepted as a valid experimental model of diabetes in the
rabbit (O¨ztu¨rk et al., 1996).
The present results show that 5-HT contracted renal
arteries isolated from control and diabetic rabbits. In arteries
from diabetic rabbits, this contraction was higher than that
obtained in arteries from control animals. This would be in
agreement with the diabetes enhancement of the pressor
response to 5-HT in pulmonary circulation (El Kashef,
1996) and the enhanced sensitivity of basilar (Van Buren
et al., 1998) and carotid (Miranda et al., 2000b) artery to 5-
HT observed in diabetic animals. Diabetes also enhances the
renal vasoconstrictor effect of adenosine (Pflueger et al.,
1999). In contrast, other studies describe that diabetes
reduces the contractile response of the rat aorta to 5-HT
(James et al., 1994; James and Hodgson, 1997).
In arteries from control rabbits, the mechanical removal
of the endothelium did not significantly modify the concen-
tration–response curve to 5-HT. This result is in accordance
with studies showing that the contractile responses to 5-HT
of bovine anterior ciliary artery (Buckley et al., 1998) and
human deferential artery (Medina et al., 1996) were unaf-
fected by removal of the endothelium. However, it has been
observed that the endothelium partially counteracts the
contractile response to 5-HT in goat middle cerebral artery
(Miranda et al., 1993), rabbit saphenous vein (Valentin et
al., 1996), human uterine artery (Karlsson et al., 1998) and
rabbit carotid artery (Miranda et al., 2000b). The present
result would suggest either that the endothelium does not
modulate the contractile response of the renal artery to 5-HT
or, more probably, that there is equilibrium between endo-
thelium-released vasodilators and vasoconstrictors. In con-
trast, in arterial segments from diabetic animals, the removal
of the endothelium induced an enhancement of the 5-HT-
induced contraction. This result shows that the endothelium
inhibits the 5-HT-induced contraction of renal arteries from
diabetic rabbits. Diabetes enhances the inhibitory activity of
the endothelium on 5-HT-induced contractions in rabbit
carotid artery (Miranda et al., 2000b). Diabetes also enhan-
ces the endothelium-dependent relaxations to histamine
(White and Carrier, 1986) and to acetylcholine (Bhardwaj
and Moore, 1988; Pieper, 1999; Alabadı´ et al., 2001). In
addition, the fact that in diabetic arteries without endothe-
lium the 5-HT-induced contraction was higher than that
obtained in control rabbits would suggest the existence of a
diabetes-induced hyperreactivity of the renal arterial smooth
muscle to 5-HT that would be partially deadened by the
enhanced modulatory activity of the endothelium.
We have investigated the participation of NO in the
modulatory action of the endothelium in the 5-HT-induced
response of renal artery from either control or diabetic rabbits.
NO is synthesised from the amino acid L-arginine by the
Ca2 + -dependent enzyme NOS. There are three isoenzymes
of NOS (Moncada et al., 1997): two constitutive isoforms,
endothelial (eNOS) and neuronal (nNOS), and one inducible
(iNOS). Incubation of renal arteries from either control or
diabetic rabbits with the inhibitor of the constitutive NOS L-
NA significantly enhanced the contractile response of arterial
segments to 5-HT. This indicates that in the presence of 5-HT,
renal arterial endothelium releases NO that partially counter-
acts the contractile response to this amine. This is in agree-
ment with data obtained in cerebral (Miranda et al., 1993),
pulmonary (Shi et al., 1998) and carotid (Miranda et al.,
2000b) arteries. The maximal contraction induced by 5-HT in
the presence of L-NAwas significantly lower in renal arteries
from diabetic rabbits than in those from control rabbits, thus
suggesting that NO was less effective at inhibiting diabetic
than control arteries, indicating a lower modulatory role of
NO in the diabetic state. Previously, we have reported that the
arterial response induced by the NO donor sodium nitroprus-
side is similar in renal arteries from control and diabetic
rabbits, thus indicating that the sensitivity of smooth muscle
cells of renal arteries to NO is not altered in our diabetic
rabbits (Alabadı´ et al., 2001).
In arteries from control rabbits, the 5-HT-induced con-
traction in rubbed arterial segments preincubated with L-NA
was significantly higher than that obtained in rubbed arteries
in the absence of the inhibitor. This would suggest that NO
is released from a non-endothelial (neuronal) NO source as
well as from endothelium in response to 5-HT, in a similar
way as described in the responses of the goat middle
cerebral artery to 5-HT (Miranda et al., 1996) and endothe-
lin-1 (Alabadı´ et al., 1997). In carotid and cerebral arteries,
vasodilator perivascular nerves that synthesise and release
NO by means of nNOS have been identified (Tomimoto et
al., 1994; Ignacio et al., 1997). NO derived from nNOS
plays a role in the control of systemic and renal hemody-
namics in the rat (Komers et al., 2000a,b). Therefore, this
nitric oxidergic perivascular nerve source might be the
responsible of the endothelium-independent modulatory
mechanisms described above in the response of the rabbit
renal artery to 5-HT. The absence, in diabetic rabbits, of
significant differences between the contractions to 5-HT in
rubbed arteries without L-NA and rubbed arteries preincu-
bated with L-NA suggests an impairment of the non-endo-
thelial source of NO in diabetes. This impairment could be,
at least partially, responsible of the hyperreactivity of the
renal artery to 5-HT in diabetes. A defective NO-dependent
renal vasodilation is responsible of the increased vasocon-
strictor sensitivity of the diabetic renal vasculature to
adenosine (Pflueger et al., 1999). Diabetes is associated
with a reduction of nNOS activity in retinal vasculature
(Roufail et al., 1998), skeletal muscle (Perreault et al.,
2000), mesenteric artery (Ferrer et al., 2000) and penile
tissue (Cellek et al., 1999) of the streptozotocin-induced
diabetic rats. In contrast, an increased activity of the nNOS
pathway has been suggested to play a role in the patho-
genesis of diabetic renal hemodynamic changes in the rat
(Komers et al., 2000a,b).
In control rabbits, the maximal contraction induced by 5-
HT in L-NA-treated unrubbed arteries was significantly
higher than that obtained in rubbed arteries preincubated
with the inhibitor. This result suggests that, in control
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animals, endothelium modulates renal arterial response to 5-
HT through the release of both NO and a vasoconstrictor.
When NO synthesis had been inhibited but not that of the
vasoconstrictor (unrubbed arteries incubated with L-NA),
the maximal tension reached was higher with respect to
contraction obtained in L-NA-treated rubbed arteries, in
which both NO and the vasoconstrictor had been removed.
Moreover, the inhibitor of the enzyme cyclooxygenase
indomethacin (Moncada and Vane, 1979) significantly
inhibited the contraction induced by 5-HT, thus suggesting
the prostanoid nature of the endothelial vasoconstrictor (i.e.
thromboxane A2). A similar result has been obtained in
human umbilical artery (De Moraes et al., 1997; Mathias et
al., 1997), guinea-pigs pulmonary veins (Shi et al., 1998)
and rabbit carotid artery (Miranda et al., 2000b).
In contrast with results obtained in arteries from control
rabbits, in diabetic rubbed renal arteries incubated with L-NA,
the contraction induced by 5-HTwas not significantly differ-
ent from that obtained with each of these two treatments
(removal of endothelium and incubation with L-NA) by
separate. This would suggest that diabetes impairs the par-
ticipation of the endothelial vasoconstrictor prostanoid.
Moreover, the incubation of diabetic arterial segments with
indomethacin enhanced the contractile response to 5-HT, thus
suggesting that the endothelial arachidonic acid derivative of
the cyclooxygenase via in diabetic arteries has vasodilator
influence (probably prostacyclin). Our results are in agree-
ment with the decreased activity of vasoconstrictor prosta-
noids (Makino and Kamata, 1998; Miranda et al., 2000a,b)
and the enhanced activity of vasodilator prostanoids (Oku-
mura et al., 2000; Alabadı´ et al., 2001) that have been
reported in diabetes. It could be hypothesised that, in the
experimental conditions of the present study, the absence of
the vasoconstrictor prostanoid would be the expression of a
compensatory mechanism addressed to minimise the delete-
rious consequences of both the hyperreactivity of renal artery
to 5-HT and the defective participation of NO.
In conclusion, diabetes enhances contractile response of
rabbit renal artery to 5-HT. In control animals, this response
is regulated by both endothelial and non-endothelial (neuro-
nal) NO and by a vasoconstrictor prostanoid. Diabetes
impairs the release of non-endothelial NO and the vaso-
constrictor prostanoid.
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